id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0025-0006,FDA,FDA-2007-D-0025,Modifications to Devices Subject to Premarket Approval (PMA) - The PMA Supplement Decision-Making Process:  Guidance for Industry and FDA Staff,Other,Guidance,2024-03-29T04:00:00Z,2024,3,2024-03-29T04:00:00Z,,2024-11-06T23:36:11Z,,1,0,09000064845f7739